Cabot Corporation (NYSE:CBT) Stock Has Average Target Price of $87.80

Cabot Corporation (NYSE:CBT) has been assigned a consensus rating of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $87.80.

A number of brokerages recently commented on CBT. Truist Financial set a $100.00 price objective on Cabot in a research report on Wednesday, August 5th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. UBS Group lowered their price target on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th.

Cabot Stock Down 1.3%

Shares of CBT opened at $72.84 on Tuesday. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $78.88 and a two-hundred day moving average price of $79.46. The stock has a market cap of $3.76 billion, a price-to-earnings ratio of 20.52, a P/E/G ratio of 8.69 and a beta of 0.83.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities analysts predict that Cabot will post 6.35 EPS for the current fiscal year.

Insider Transactions at Cabot

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the sale, the chief executive officer owned 404,134 shares of the company’s stock, valued at approximately $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 229,597 shares of company stock valued at $19,646,746 in the last quarter. 3.08% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in CBT. Root Financial Partners LLC acquired a new position in shares of Cabot during the third quarter worth approximately $27,000. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Cabot during the 2nd quarter valued at $33,000. Global Retirement Partners LLC bought a new stake in Cabot in the second quarter worth about $88,000. Rockefeller Capital Management L.P. increased its position in Cabot by 115.3% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company’s stock worth $76,000 after buying an additional 617 shares during the last quarter. Finally, Allworth Financial LP purchased a new stake in Cabot in the 2nd quarter worth about $145,000. 93.18% of the stock is owned by institutional investors and hedge funds.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.